Cargando…

Five-lipoxygenase-activating protein-mediated CYLD attenuation is a candidate driver in hepatic malignant lesion

Hepatocellular carcinoma (HCC) is an inflammation-associated cancer. However, the lipid pro-inflammatory mediators have only been seldom investigated in HCC pathogenesis. Cylindromatosis (CYLD) attenuation is involved in hepatocarcinogenesis. Here, we aimed to evaluate the significance of hepatic li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Kun-kai, Zheng, Xue-hua, Bréchot, Christian, Zheng, Xiao-ping, Zhu, Dan-hua, Huang, Rong, Zhang, Yan-hong, Tao, Jing-jing, Lou, Yi-jia, Li, Lan-juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376481/ https://www.ncbi.nlm.nih.gov/pubmed/35978827 http://dx.doi.org/10.3389/fonc.2022.912881

Ejemplares similares

Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
por: Erol, Adnan
Publicado: (2022)

Impact of CYLD on chromatin structure and histone methylation in malignant melanoma
por: Schott, Mandy, et al.
Publicado: (2022)

CYLD in health and disease
por: Marín-Rubio, José L., et al.
Publicado: (2023)

Truncation of the Deubiquitinating Domain of CYLD in Myelomonocytic Cells Attenuates Inflammatory Responses
por: Tsagaratou, Ageliki, et al.
Publicado: (2011)

SPATA2 and CYLD inhibit T cell infiltration into colorectal cancer via regulation of IFN-γ/STAT1 axis
por: Tan, Tze Guan, et al.
Publicado: (2022)

Germline and somatic drivers in inherited hematologic malignancies
por: Zoller, Julian, et al.
Publicado: (2023)

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling
por: Elliott, Paul R., et al.
Publicado: (2016)

SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes
por: Kupka, Sebastian, et al.
Publicado: (2016)

Driver Gene Alterations in Malignant Progression of Gastric Cancer
por: Dong, Yuanqiang, et al.
Publicado: (2022)

A Five-Parameter Logistic Model to Predict the Possibility of Misdiagnosis for Improving the Specificity of Lugol Chromoendoscopy in the Diagnosis of Esophageal Neoplastic Lesions
por: Guo, Zijun, et al.
Publicado: (2022)

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
por: Wang, Kun, et al.
Publicado: (2019)

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
por: Massoumi, Ramin, et al.
Publicado: (2009)

Deep Learning for Differentiating Benign From Malignant Parotid Lesions on MR Images
por: Xia, Xianwu, et al.
Publicado: (2021)

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma
por: Xu, Jian-Zhao, et al.
Publicado: (2021)

A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family
por: Zhu, Ruizheng, et al.
Publicado: (2020)

Phospholipid Phosphatase 4 as a Driver of Malignant Glioma and Pancreatic Adenocarcinoma
por: Tian, Wenxiu, et al.
Publicado: (2021)

CYLD tumour supressor regulates ciligenesis
por: Eguether, T, et al.
Publicado: (2012)

Editorial: Transcription Factors Drivers of Malignancy, Progression and Poor Outcomes in Breast Cancer
por: Parisi, Eva, et al.
Publicado: (2022)

Long Non-Coding RNA Cancer Susceptibility Candidate 9 Regulates the Malignant Biological Behavior of Nasopharyngeal Carcinoma Cells by Targeting miR-497-5p/Wnt3a/β-catenin Signaling Pathway
por: Lei, Yue, et al.
Publicado: (2022)

Inhibition of 5-Lipoxygenase Pathway Attenuates Acute Liver Failure by Inhibiting Macrophage Activation
por: Li, Lu, et al.
Publicado: (2014)

MRI-Based Machine Learning in Differentiation Between Benign and Malignant Breast Lesions
por: Zhao, Yanjie, et al.
Publicado: (2021)

An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions
por: Zhang, Renzhi, et al.
Publicado: (2022)

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Qian, Xiaohan, et al.
Publicado: (2021)

Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer’s phenotype
por: Li, Jian-Guo, et al.
Publicado: (2017)

Transcriptome Based System Biology Exploration Reveals Homogeneous Tumorigenicity of Alimentary Tract Malignancy
por: Lu, Yu-Chen, et al.
Publicado: (2021)

CYLD deficiency causes auditory neuropathy due to reduced neurite outgrowth
por: Yang, Song, et al.
Publicado: (2021)

Interactions of Colorectal Cancer, Dietary Fats, and Polymorphisms of Arachidonate Lipoxygenase and Cyclooxygenase Genes: A Literature Review
por: Gholamalizadeh, Maryam, et al.
Publicado: (2022)

Editorial: Immunotherapy for NSCLC with oncogenic driver variants
por: Du, Yijia, et al.
Publicado: (2022)

UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)

The cylindromatosis (CYLD) gene and head and neck tumorigenesis
por: Verhoeft, Krista Roberta, et al.
Publicado: (2016)

Genetic Testing in CYLD Cutaneous Syndrome: An Update
por: Nagy, Nikoletta, et al.
Publicado: (2021)

Gynaecological cylindroma in association with CYLD gene mutation
por: Khoury, Emma, et al.
Publicado: (2022)

Second Malignant Neoplasms in Patients With Rhabdomyosarcoma
por: Zhen, Hongnan, et al.
Publicado: (2021)

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
por: Qiu, Yuan, et al.
Publicado: (2022)

A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib
por: Chen, Dong, et al.
Publicado: (2020)

The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma
por: Oguh-Olayinka, Lily, et al.
Publicado: (2019)

A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of (68)Ga-NOTA-PRGD2 and (18)F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions
por: Xie, Fei, et al.
Publicado: (2022)

Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy
por: Zhao, Xin, et al.
Publicado: (2022)

Editorial: Cancer-Associated Defects in the DNA Damage Response: Drivers for Malignant Transformation and Potential Therapeutic Targets
por: van Vugt, Marcel A. T. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k2b8pnp42lho3vln00sai3km4p